Having spent a very good a part of my journalistic profession protecting crime tales, it’s onerous for me to avoid any crime or medical forensic drama. So when Scarpetta premiered on Amazon Prime Video on March 11, I used to be instantly drawn in. Partly for the forensic angle, partly as a result of the collection is predicated on Patricia Cornwell’s bestselling novels.
Starring Nicole Kidman as forensic pathologist Kay Scarpetta, the present follows advanced investigations that mix medical experience with felony circumstances. However because the story unfolds, it strikes past conventional forensic themes and into one thing extra surprising: 3D bioprinted human organs.
How the Amazon Prime present Scarpetta exhibits 3D bioprinted organs will appear like. Picture courtesy of Amazon Prime.
A central a part of the plot revolves round a fictional biotech firm, Thor Labs, which is portrayed as already able to 3D bioprinting human organs in microgravity, an surroundings scientists consider may make it simpler to construct advanced organic buildings.
In actuality, the closest real-world equal to the present’s Thor Labs is Redwire, which conducts bioprinting experiments aboard the Worldwide Area Station. And whereas it has already demonstrated early tissue printing in microgravity, it stays removed from producing totally transplantable human organs, in pre-clinical trials or past.
Reside human coronary heart tissue bioprinted with Redwire’s BioFabrication Facility aboard the ISS. The tissue was efficiently returned to Earth in April 2024. Picture courtesy of Redwire.
The present has taken an actual idea, space-based bioprinting, and pushes it a decade or extra forward of the place the science stands right now. That’s the place the road between fiction and actuality begins to blur. The query is: how shut are we, actually?
No one is printing a completely transplantable human coronary heart, kidney, or liver but. However a number of teams are clearly nearer than the remainder, they usually fall into three teams: organ-scale scaffolds and bridge tissues, vascularization, and implantable tissues. Probably the most aggressive efforts embrace United Therapeutics/3D Techniques, ARPA-H-backed work at Carnegie Mellon, and analysis at Stanford, whereas extra clinically centered work is going on at Wake Forest, Poietis, KIT, and in Sydney’s 3D printed pores and skin trials. On the similar time, on-orbit bioprinting analysis continues in locations like Tsinghua College in China. Right here’s a more in-depth have a look at among the teams main this work:
United Therapeutics + 3D Techniques (U.S.)
That is most likely one of the crucial bold efforts within the subject. United Therapeutics (UT) is creating a 3D printed lung scaffold as a part of its ULung program, designed to be populated with human cells. ULung is considered one of UT’s 4 pre-clinical and medical organ and organ different platforms designed to handle the continued scarcity of transplantable organs for sufferers with end-stage organ illness. The corporate says these buildings have already demonstrated fuel alternate in animal fashions and can be working towards printed kidneys and livers. Whereas that is nonetheless removed from a transplant-ready organ, it stays one of many clearest examples of how far organ-scale bioprinting is being pushed right now.
3D bioprinted lung lobe. Picture courtesy of United Therapeutics.
ARPA-H PRINT program + Carnegie Mellon and Adam Feinberg (U.S.)
That is an important U.S. authorities push. ARPA-H launched its PRINT program to pursue personalised, on-demand organs that will not require immunosuppressive medicine. Among the many researchers concerned is Adam Feinberg of Carnegie Mellon College, one of many main consultants in 3D bioprinting, who secured help for a 3D bioprinted liver tissue undertaking designed as a brief different for acute liver failure. The purpose is to help sufferers for 2 to 4 weeks whereas their very own liver recovers. This isn’t a everlasting substitute, however one of the crucial lifelike short-term options to help sufferers slightly than substitute the organ totally.
FRESH 3D bioprinted perfusable liver tissue inside a bioreactor. Picture courtesy of Carnegie Mellon.
Stanford’s Mark Skylar-Scott (U.S.)
One of many greatest challenges in bioprinting is vascularization, the power to create blood vessel networks inside an organ. In 2025, researchers at Stanford College, together with bioengineer Mark Skylar-Scott, developed new instruments to design and print these vascular buildings. This issues as a result of with no working blood provide, bigger tissues can’t survive. Whereas that is nonetheless not prepared for printing a transplant-ready organ, it’s engaged on one of many key issues the sphere wants to resolve for any future printed organ to work.
In the back of the lab, subsequent to a multi-axis bioprinter — a customized machine developed in-house by the Lewis Lab, first pioneered by Jennifer Lewis and her then-postdoc Mark Skylar-Scott. Immediately, it anchors a lot of the lab’s effort to print advanced, dwelling tissues. Picture courtesy of 3DPrint.com.
Wake Forest Institute for Regenerative Medication and Anthony Atala (U.S.)
Wake Forest stands out for bringing analysis into real-world use. The institute says it was the primary to engineer lab-grown organs that had been efficiently implanted in people, and it continues to work throughout a variety of tissue and organ analysis. Not all of this work includes 3D bioprinting; a few of its best-known outcomes come from broader tissue engineering, however relating to actual progress in organ substitute, Wake Forest stays one of the crucial credible teams within the subject, led by regenerative drugs pioneer Anthony Atala.
Younger-Joon Seol on the Wake Forest Institute for Regenerative Medication (WFIRM) demonstrates Bioprinting muscle tissue. Picture courtesy of WFIRM.
Poietis (France)
In Europe, Poietis stands out not for claiming full organs, however for working towards implantable tissues. The corporate says its laser-based bioprinting platform is designed to fulfill the consistency and high quality wanted for medical use, with a transparent concentrate on transferring from design to implantation. This implies it’s creating methods to reliably produce dwelling tissues for actual medical use. It makes Poietis a powerful instance in Europe.
Poietis’ NGB-R bioprinting platform. Picture courtesy of Poietis.
KIT + Ute Schepers (Germany)
Work on the Karlsruhe Institute of Expertise on a tiny 3D printed child coronary heart valve exhibits how the sphere could attain the clinic sooner by means of components of organs slightly than complete ones. On this case, researchers used 3D printing to create a biodegradable coronary heart valve scaffold designed to be seeded with the affected person’s personal cells and develop contained in the physique. A valve will not be a full coronary heart, however it’s a extra lifelike near-term goal and nonetheless medically essential. It’s a very good instance of how progress on this area is prone to occur, not by means of totally printed organs in a single day, however by means of smaller, implantable buildings.
3D printed child coronary heart valve. Picture courtesy of Uli Deck/dpa/Karlsruhe Institute of Expertise.
Tsinghua-led work in China
China can be energetic on this area, with establishments like Tsinghua College main analysis efforts. Public profiles from Tsinghua present energetic analysis in cardiac regeneration, on-orbit bioprinting, vascular networks, AI-driven bioprinting, and even papers about on-demand organ manufacturing. This doesn’t imply China has secretly solved printed organs. It exhibits the nation is making progress in a number of key areas directly, together with space-based bioprinting, blood vessel development, and organoid analysis.
Perfusable ventricle constructs fabricated by SPIRIT. Picture courtesy of Tsinghua College.
ANU and the Sydney pores and skin trial
On the Australian Nationwide College, bioprinting is being explored as a path towards future organs, with present work centered on printing dwelling cells, tissue-like buildings, and organoids for illness modeling. A clearer instance is Sydney’s world-first 3D printed pores and skin trial utilizing a affected person’s personal cells. Pores and skin will not be a kidney, however it’s nonetheless a dwelling, printed tissue utilized in an actual medical setting, displaying the place the sphere is beginning to have an actual influence.
Dr Jo Maitz with NSW Well being Minister Ryan Park and Strathfield MP Jason Yat-Sen Li throughout a go to to Harmony Burns Unit. Picture courtesy of Harmony Burns Unit.
It is going to possible be a while earlier than we see the sort of lab-grown, microgravity-grown organs prepared for medical use, as seen in Scarpetta. However the thought will not be totally out of attain. If something, it’s a reminder of the place the expertise is heading, and a great way to place the highlight on a subject that’s transferring ahead.
Nicole Kidman as forensic pathologist Kay Scarpetta in Scarpetta. Picture courtesy of Amazon Prime.
Subscribe to Our E mail Publication
Keep up-to-date on all the most recent information from the 3D printing business and obtain data and gives from third get together distributors.
Add your 3D Fashions and get them printed rapidly and effectively.
